The Department of Health and Human Services (HHS) announced on September 30 that it is doubling its funding for childhood cancer research from $50 million to $100 million. This strategic increase aims to accelerate the development of diagnostics, treatments, and prevention measures that include the innovative use of artificial intelligence.

The enhanced funding will enable HHS to leverage AI technologies to analyze electronic health records and claims data. This data-driven approach is intended to inform research strategies and clinical trial design, ultimately improving outcomes for children with cancer.

This initiative, known as the Childhood Cancer Data Initiative, was originally established during the previous Trump administration in 2019. By significantly increasing investments in such vital research, HHS is demonstrating a commitment to combating childhood cancer through modern technology and a robust data-driven approach.